試す 金 - 無料
There's crushing news for people who want to live long
Mint Bangalore
|April 21, 2025
A wonder drug that a wealthy longevity seeker was testing on himself may have turned out to be a dud
A few days ago, Bryan Johnson, a centi-millionaire who has spent millions on reversing ageing—especially his own—posted some bad news for humanity on his YouTube channel. Rapamycin, which for a long time has been the most promising molecule in our quest to prolong youth, was not making him younger; instead, it was "accelerating" his ageing.
Johnson, who is 47 and looks 46, conducts various experiments on himself in his effort to live like a young man for a very long time. I am counting on him. His food consumption is so calibrated that he knows the number of calories he has gulped. He does not eat after 11 am, unless he has to meet people socially and must eat at ungodly hours like 7 pm just to shut them up. He sleeps around 8:30 pm, alone. I know he has high standards for himself because he recently visited Delhi, probably out of ignorance, and refused to breathe the air for too long. Among the most important things he was performing on himself was taking small quantities of rapamycin, a drug that is chiefly used to prevent the body's rejection of organ transplants. It does not have approval as an anti-ageing drug, though it is widely believed to have potential for that. The compound had extended the lifespan of mice and worms beyond ambiguity, and of other animals, too. Johnson was its most famous human test subject.
このストーリーは、Mint Bangalore の April 21, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Mint Bangalore からのその他のストーリー

Mint Bangalore
Small stores slow to pass on GST rate cuts
maximum retail prices (MRPs). ‘They have the option to affix new price stickers.
2 mins
October 22, 2025

Mint Bangalore
Keppel buys 49% in Cleantech, takes control
cation,” a Shell spokesperson said in an emailed response.
1 mins
October 22, 2025
Mint Bangalore
Deloitte's AI debacle in Australia isa warning for all early adopters
That a report riddled with AI hallucinations was sent to a government should be a wake-up call
3 mins
October 22, 2025
Mint Bangalore
UltraTech fires up expansion, north peers left in the cold
An-India focused UltraTech Cement announced the fourth phase of its capacity expansion alongside its September quarter (Q2FY26) results last week.
1 mins
October 22, 2025
Mint Bangalore
Why ICICI grit beats HDFC gloss
The Street reacted differently to the September quarter (Q2FY26) results of India’s top private sector banks, HDFC Bank and ICICI Bank.
2 mins
October 22, 2025
Mint Bangalore
SC raps insurance firms for filing needless appeals
The court warned against contesting workmen's compensation cases if liability is not disputed
1 mins
October 22, 2025
Mint Bangalore
India’s sunshine law: Clouded by the data privacy bill
In March 2003, the Supreme Court passed a historic verdict that filled a legislative gap.
3 mins
October 22, 2025

Mint Bangalore
EVs, clean tech steer IJF bets
The India-Japan Fund has invested just a third of its $600-mn corpus so far; plans full deployment in three years
3 mins
October 22, 2025
Mint Bangalore
CCI clears Torrent's JB stake buy proposal
Fair trade regulator Competition Commission of India (CCI) on Tuesday cleared Torrent Pharmaceuticals Ltd's proposed acquisition of a stake in JB Chemicals and Pharmaceuticals, subject to voluntary modifications offered by the companies.
1 min
October 22, 2025

Mint Bangalore
Venu Srinivasan reappointed for life at Tata Trusts
Tata Trusts has unanimously reappointed Venu Srinivasan as a trustee for life and all eyes are now on the upcoming decision regarding Mehli Mistry’s renewal, amid reported internal divisions within the organisation.
2 mins
October 22, 2025
Listen
Translate
Change font size